These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 17347463)

  • 1. Bivalirudin in acute coronary syndromes.
    Sanmartin M
    N Engl J Med; 2007 Mar; 356(10):1069-70; author reply 1070-1. PubMed ID: 17347463
    [No Abstract]   [Full Text] [Related]  

  • 2. Bivalirudin for patients with acute coronary syndromes.
    Stone GW; McLaurin BT; Cox DA; Bertrand ME; Lincoff AM; Moses JW; White HD; Pocock SJ; Ware JH; Feit F; Colombo A; Aylward PE; Cequier AR; Darius H; Desmet W; Ebrahimi R; Hamon M; Rasmussen LH; Rupprecht HJ; Hoekstra J; Mehran R; Ohman EM;
    N Engl J Med; 2006 Nov; 355(21):2203-16. PubMed ID: 17124018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accounting for ACUITY.
    Bittl JA
    N Engl J Med; 2006 Nov; 355(21):2249-50. PubMed ID: 17124024
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA panel votes against approval for bivalirudin.
    Piña I
    Circulation; 1999 Mar; 99(10):1277. PubMed ID: 10077507
    [No Abstract]   [Full Text] [Related]  

  • 5. Bivalirudin in acute coronary syndromes.
    Bonvini RF; Verin V; Righini M
    N Engl J Med; 2007 Mar; 356(10):1070; author reply 1070-1. PubMed ID: 17354307
    [No Abstract]   [Full Text] [Related]  

  • 6. Bivalirudin (Angiomax) for angioplasty.
    Med Lett Drugs Ther; 2001 Apr; 43(1103):37-8. PubMed ID: 11331441
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and safety of bivalirudin versus heparins in reduction of cardiac outcomes in acute coronary syndrome and percutaneous coronary interventions.
    Singh S; Molnar J; Arora R
    J Cardiovasc Pharmacol Ther; 2007 Dec; 12(4):283-91. PubMed ID: 18172222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bivalirudin as an anticoagulant during percutaneous coronary interventions in acute coronary syndromes: strengths and doubts].
    Savonitto S; Morici N
    Rev Esp Cardiol; 2011 May; 64(5):361-4. PubMed ID: 21482005
    [No Abstract]   [Full Text] [Related]  

  • 9. Bivalirudin and transradial access--the end of the bleeding era for catheterization procedures?
    Badheka A; Cohen MG
    J Invasive Cardiol; 2011 Mar; 23(3):4 p preceding 108. PubMed ID: 21364239
    [No Abstract]   [Full Text] [Related]  

  • 10. Bivalirudin, a bivalent, thrombin specific anticoagulant as an alternative to heparin in interventional procedures as an alternative to heparin in interventional procedures.
    Chew DP
    Hamostaseologie; 2002 Aug; 22(3):60-6. PubMed ID: 12215763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bivalirudin during primary PCI in acute myocardial infarction.
    Stone GW; Witzenbichler B; Guagliumi G; Peruga JZ; Brodie BR; Dudek D; Kornowski R; Hartmann F; Gersh BJ; Pocock SJ; Dangas G; Wong SC; Kirtane AJ; Parise H; Mehran R;
    N Engl J Med; 2008 May; 358(21):2218-30. PubMed ID: 18499566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caspofungin acetate, bivalirudin.
    Am J Health Syst Pharm; 2001 Oct; 58(19):1807-9. PubMed ID: 11596694
    [No Abstract]   [Full Text] [Related]  

  • 13. Commentary: bivalirudin is a safe and effective anticoagulant in the percutaneous treatment of complex infrainguinal disease.
    Walker CM
    J Endovasc Ther; 2010 Feb; 17(1):37-8. PubMed ID: 20199264
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety and efficacy of bivalirudin monotherapy in patients with diabetes mellitus and acute coronary syndromes: a report from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial.
    Feit F; Manoukian SV; Ebrahimi R; Pollack CV; Ohman EM; Attubato MJ; Mehran R; Stone GW
    J Am Coll Cardiol; 2008 Apr; 51(17):1645-52. PubMed ID: 18436116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letter by De Servi and Navarese regarding article, "Prognostic modeling of individual patient risk and mortality impact of ischemic and hemorrhagic complications: assessment from the Acute Catheterization and Urgent Intervention Triage Strategy trial".
    De Servi S; Navarese E
    Circulation; 2010 Sep; 122(12):e461; author reply e462-3. PubMed ID: 20855666
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale.
    Stone GW; Bertrand M; Colombo A; Dangas G; Farkouh ME; Feit F; Lansky AJ; Lincoff AM; Mehran R; Moses JW; Ohman M; White HD
    Am Heart J; 2004 Nov; 148(5):764-75. PubMed ID: 15523305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Switching from Enoxaparin to Bivalirudin in Patients with Acute Coronary Syndromes without ST-segment Elevation who Undergo Percutaneous Coronary Intervention. Results from SWITCH--a multicenter clinical trial.
    Waksman R; Wolfram RM; Torguson RL; Okubagzi P; Xue Z; Suddath WO; Satler LF; Kent KM
    J Invasive Cardiol; 2006 Aug; 18(8):370-5. PubMed ID: 16877786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bivalirudin and DES: a PCI strategy that pays.
    Applegate RJ
    J Invasive Cardiol; 2007 Feb; 19(2):69-70. PubMed ID: 17268040
    [No Abstract]   [Full Text] [Related]  

  • 19. Bivalirudin-associated intracoronary thrombosis during gamma-brachytherapy and its experimental validation in acute swine model.
    Kuchulakanti PK; Satler LF; Rha SW; Waksman R
    Catheter Cardiovasc Interv; 2004 Jun; 62(2):209-13. PubMed ID: 15170713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of clopidogrel pretreatment effect on the relative efficacy of bivalirudin with provisional glycoprotein IIb/IIIa blockade compared to heparin with routine glycoprotein IIb/IIIa blockade: a REPLACE-2 substudy.
    Saw J; Lincoff AM; DeSmet W; Betriu A; Rutsch W; Wilcox RG; Kleiman NS; Wolski K; Topol EJ;
    J Am Coll Cardiol; 2004 Sep; 44(6):1194-9. PubMed ID: 15364319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.